Skip to main content
PMC home page
Plants logoLink to Plants
. 2022 Jan 14;11(2):218. doi: 10.3390/plants11020218

Oral and Topical Anti-Inflammatory Activity of Jatropha integerrima Leaves Extract in Relation to Its Metabolite Profile

Engy A Mahrous 1,*, Ahmed H Elosaily 2, Abeer A A Salama 3, Ahmed M Salama 2, Soheir M El-Zalabani 1
Editors: Yun-Soo Seo, Joong-Sun Kim
PMCID: PMC8781579  PMID: 35050106

Abstract

Jatropha integerrima Jacq., family: Euphorbiaceae, is used in India and subtropical Africa to treat different skin conditions. In this study we evaluated the anti-inflammatory activity of J. integerrima leaves extract (JILE) using rat paw edema model. The extract was administered orally (200 and 400 mg/kg) or applied topically as creams at 2.5, 5, and 10% strength. Four hours post-treatment, maximum reduction of edema volume by 63.09% was observed after oral administration of JILE (400 mg/kg) as compared to indomethacin with 60.43%. The extract anti-inflammatory effect was accompanied by a decrease in NO, prostaglandin PGE2, TNF-α and PKC levels by 19, 29.35, 16.9, and 47.83%, respectively. Additionally, topical applications of JILE showed dose dependent reduction in paw edema and resulted in normalized levels of PGE2, TNF-α, and PKC when used as 10% cream. Signs of inflammations were reduced or absent from paw tissue of animals receiving JILE either orally or topically. Finally, liquid chromatography/mass spectrometry analysis of JILE resulted in the annotation of 133 metabolites including 24 diterpenoids, 19 flavonoids, 10 phenolic acid conjugates, 8 cyclic peptides, 6 phytosterols, 4 sesquiterpenes, and 4 coumarins. Several of the annotated metabolites have known anti-inflammatory activity including vitexin, isovitexin, fraxitin, scopeltin, stigmasterol, and many diterpenoidal derivatives.

Keywords: anti-inflammatory, diterpenoids, cyclic peptide, Euphorbiaceae, hydroxyl fatty acids Jatropha integerrima, vitexin, UPLC/MS-MS

1. Introduction

The genus Jatropha (family Euphorbiaceae) has a wide distribution in tropical and subtropical regions especially South America, West Africa, India, and Southeast Asia [1,2]. Many members of the genus were used medicinally in their indigenous countries such as J. gossypifolia, J. curcas, J. chevalieri, and J. multifida [3]. Leaves and latex from Jatropha plants are especially useful in treating skin conditions such as ulcers, blisters, eczema and also to accelerate wound healing [4,5,6]. The genus is rich in bioactive secondary metabolites especially diterpenoids of tigliane, lathyrane, and jatrophane skeletons which exist mainly as esters [7,8]. However, among more than 175 Jatropha species, only few species were chemically investigated. As a result of these investigations, many structurally unique and bioactive phytochemicals were identified including flavonoids, cyclic peptides, lignans, and diterpenes [1,3].

Jatropha integerrima Jacq (syn. Jatropha pandurifolia And.), also known as spicy jatropha, is cultivated around the world as an ornamental shrub due to its showy bright red flowers. Its leaves are used as poultice in India and Bangladesh to treat different conditions including eczema, pruritus and skin warts [9,10]. Phytochemical investigation of J. integerrima identified coumarins [11], cyclic peptides [12], neolignans [13], and several novel diterpenes with different biological activities [14,15]. More than 16 new compounds were isolated from J. integerrima in the past decade alone [13,14,15], indicating a rich metabolome that is yet to be fully explored. Recent pharmacological investigation of the plant showed promising antimicrobial activity of extracts and essential oils obtained from seeds and leaves [16,17] and strong antioxidant activity of the flowers extract [18].

Based on the accumulated literature and the known folk use of J. integerrima, this study was performed to investigate the anti-inflammatory effect of J. integerrima leaves extract (JILE) when administered orally or applied topically. Anti-inflammatory activity was assessed in rat paw edema model through measuring edema volumes and levels of inflammatory mediators nitric oxide (NO), tumor necrosis factor-α (TNF-α), prostaglandin E2 (PGE2), and protein kinase C (PKC) in addition to examining histopathological features of paw tissue. Furthermore, ultra-performance liquid chromatography coupled to high resolution mass spectrometry (UPLC-MS) was used to identify secondary metabolites in JILE through tandem mass fragmentation to assist with identifying metabolites that can contribute to the anti-inflammatory activity of the plant.

2. Results

2.1. Acute Toxicity Study

Rats treated with J. integerrima leaves extract (JILE) at a high dose of 5 g/kg did not show any skin abnormalities or changes in respiratory, circulatory, and somatomotor activities as well as behavior pattern.

2.2. Evaluation of Oral Anti-Inflammatory Effect of Jatropha integerrima Leaves Extract

The subplanter injection of 100 μL of 1% sterile carrageenan into the rat hind paw elicited an inflammation manifested by swelling, erythema and a time-dependent increase in paw edema by 61.82, 77.58, 87.24%, and 66.37% after 1, 2, 3, and 4 h after injection, as compared with precarrageenan control values, Figure 1. This observed response to carrageenan injection follows the same pattern of maximum inflammation after 3 h as previously reported [19].

Figure 1.

Figure 1

Open in a new tab

Effect of oral administration of ethanol extract of Jatropha integerrima leaves on edema volume. One way ANOVA and Fishers LSD comparison test were used, p < 0.05; a: significantly different from carrageenan control group at respective time point; b: significantly different from indomethacin group at respective time point.

Pretreatment with JILE (200 mg/kg and 400 mg/kg, orally) showed a significant inhibition of edema formation by 53.09% and 55.17% after 1 h, 42.15% and 44.87%, after 2 h, 39.04% and 48.03% after 3 h, and 39.01% and 63.90% after 4 h, respectively, as compared with carrageenan control group at the same time. In the same assay, indomethacin treatment (25 mg/kg) resulted in a 61.17%, 48.56%, 63.9%, and 60.43% reduction of edema volume, as compared with that of carrageenan group after 1, 2, 3, and 4 h postcarrageenan injection, respectively, Figure 1.

By the end of the experiment, serum NO level increased by 44% in animals that received only carrageenan as compared with normal control group. Animals that were pre-treated with indomethacin and J. integerrima at 200 mg/kg and 400 mg/kg had significantly decreased serum NO levels by 17%, 13%, and 19%, respectively, as compared with that of animals that received carrageenan only (p < 0.05), Table 1.

Table 1.

Effect of oral administration of Jatropha integerrima leaves extract (JILE) on different inflammation biomarkers.

Control Carrageenan Indomethacin
25 mg/kg		 JILE
200 mg/kg		 JILE
400 mg/kg
NO
(µmol/L)		 16.00 ± 1.29 23.00 ± 0.676 a 19.03 ± 0.3 ab 19.9 ± 0.08 ab 18.55 ± 0.39 b
PGE2 (pg/mL) 251.28 ± 4.16 498.8 ± 37.04 a 354.88 ± 5.36ab 514.88 ± 5.36 a 352.4 ± 23.52 ab
TNF-α (pg/mL) 1581.92 ± 10.88 2194.56 ± 99.52 a 1804.8 ± 7.84 ab 2104.96 ± 4.16 a 1823.68 ±0.16 ab
PKC (pg/mL) 870.4 ± 99.705 1505.35 ± 5.78 a 842.35 ± 153.85 b 805.8 ± 62.985 b 785.4 ± 23.29 b
Open in a new tab

Data were expressed as mean ± SD. Statistical analysis was carried out by one-way ANOVA, followed by Tukey’s HSD test for multiple comparisons. a: significantly different from normal control (Saline), b: significantly different from carrageenan control at p < 0.05.

Similarly, after 4 h following carrageenan injection, serum levels of inflammation mediators such as PGE2, TNF-α, and PKC were elevated by 98.5%, 38.75%, and 72.94%, respectively, as compared with that of normal control group. Animals pretreated with indomethacin had their levels of PGE2 decreased by 28.85%, TNF-α by 17.76%, and PKC by 44%. Meanwhile, pretreatment with JILE at 200 mg/kg caused insignificant changes in serum levels of TNF-α and PGE2 (p > 0.05) but reduced PKC by 46.47%, Table 1. Meanwhile, pretreatment with JILE at a dose of 400 mg/kg decreased PGE2 by 29.35%, TNF-α by 16.90% and PKC by 47.83%, as compared with carrageenan control group resulting in restoring serum levels of NO and PKC to their basal levels and were not significantly different from the effect observed with indomethacin treatment (p > 0.05).

The paw tissue in the healthy group and the group treated with carrageenan and indomethacin displayed normal histological features (Figure 2a,b), while the carrageenan treated group showed a few inflammatory cells infiltration in the dermal tissue and massive inflammatory cell infiltration in the subcutaneous tissue (Figure 2c). Mild focal inflammatory aggregation in subcutaneous tissue was noticed in the group treated with JILE (200 mg/kg) with normal dermal tissue (Figure 2d) while the dermal and subcutaneous tissues appeared intact in the group treated with JILE at 400 mg/kg, (Figure 2e).

Figure 2.

Figure 2

Open in a new tab

Photomicrographs of subcutaneous and dermal tissues of treated rats. (a) control group; (b) indomethacin group; (c) carrageenan group; (d) group receiving oral 200 mg/kg of J. integerrima leaves extract; and (e) group receiving oral 400 mg/kg of J. integerrima leaves extract. Arrows refer to inflammatory cell infiltration.

2.3. Evaluation of Topical Anti-Inflammatory Activity of Jatropha integerrima Leaves Extract

Rats given J. integerrima cream in the skin irritation test showed no sensitivity or irritation. The subplantar injection of carrageenan into the rat hind paw elicited an inflammation as previously mentioned in Section 2.2. Topical application of base non-medicated cream and 2.5% strength JILE cream before carrageenan injection showed no significant inhibition of edema formation at all-time points as compared with that of carrageenan group, Figure 3. Meanwhile topical application of higher strength JILE creams (5% and 10%) showed a significant inhibition of edema formation at all-time points especially after 4 h by 58.27% and 68.96%, respectively, as compared with that of untreated animals. In addition, the effect produced upon application of 10% JILE cream was superior to standard hydrocortisone cream (p < 0.05), Figure 3.

Figure 3.

Figure 3

Open in a new tab

Effect of topical administration of Jatropha integerrima cream on edema volume in rat hind paw model. One way ANOVA and Fishers LSD comparison test* were used in data analysis, p < 0.05; a significantly different from carrageenan control value at respective time point. b significantly different from hydrocortisone group value at respective time point.

Four hours postcarrageenan injection, inflammatory mediators were measured. An increased serum NO levels by 39.66% and 35.81% were observed in carrageenan treated animals and in animals treated with base cream, respectively, as compared with that of healthy control group. Animals that were treated with hydrocortisone cream and JILE cream at 2.5%, 5% and 10% showed significantly decreased serum NO levels by 14.84%, 10.92%, 17.04%, and 18.04%, respectively, as compared with that of untreated animals, Table 2.

Table 2.

Effect of topical administration of ethanol extract of Jatropha integerrima cream on different inflammation biomarkers.

Control Carrageenan Hydrocortisone
1% Cream		 Base JILE
2.5% Cream		 JILE
5% Cream		 JILE
10% Cream
NO (µmol/L) 17.9 ± 0.7 25 ± 0.7 a 21.29 ± 0.6 ab 24.31 ± 0.1 a 22.27 ± 0.59 ab 20.74 ± 0.58 ab 20.49 ± 0.08 ab
PGE2 (pg/mL) 215.4 ± 1.5 286.2 ± 0.4 a 223.4 ± 0.2 b 284.4 ± 1.8 a 256.4 ± 1.4 ab 243.4 ± 1.1 ab 216.4 ± 1.1 b
TNF-α (pg/mL) 1561.9 ± 13.6 1903.9 ± 62.9 a 1615.9 ± 15.68 b 1857.9 ± 78.1 a 1804.5 ± 23.7 a 1779.9 ± 4.4 ab 1609.9 ± 22.3 b
PKC (pg/mL) 854.9 ± 22.8 1259.9 ± 4.4 a 854.98 ± 15.1 b 1251.9 ± 26.4 a 965.98 ± 9.8 ab 924.9 ± 11.1 ab 839.9 ± 2.2 b
Open in a new tab

Data were expressed as mean ± SD. Statistical analysis was carried out by one-way ANOVA followed by Tukey’s HSD test for multiple comparisons. a: Significantly different from normal control (Saline) at p < 0.05. b: Significantly different from carrageenan control at p < 0.05.

As expected for animals receiving carrageenan only or treated with base cream, levels of inflammatory mediators were all elevated. An increase of serum levels by 32.86% and 32.03% in case of PGE2, 21.89% and 18.95% for TNF-α, and 47.37% and 46.43% in case of PKC were observed in animals that received no treatment or base cream only, respectively. Treatment with hydrocortisone resulted in a decrease in serum levels of PGE2 by 21.94%, TNF-α by 15.12%, and PKC by 32.13% when compared with that of untreated group. Meanwhile, pretreatment with cream containing 2.5% of JILE decreased PGE2 and PKC levels by 10.41% and 23.32%, respectively, while animals treated with cream containing 5% JILE decreased PGE2, TNF-α and PKC by 14.95%, 6.51%, and 26.58%, respectively, as compared with that of carrageenan group. Meanwhile, animals that received cream containing 10% of extract showed normalized serum levels of TNF-α, PKC, and PGE2, as compared with that of control group, as did treatment with hydrocortisone cream, Table 2.

The paw tissue in the healthy group and group treated with carrageenan and hydrocortisone displayed normal histological features (Figure 4a,c), except for few inflammatory cells in the hydrocortisone group. Animals that were injected with carrageenan but received no further treatment showed massive inflammatory cell infiltration in the subcutaneous tissue (Figure 4b). Hemorrhages, inflammatory cells, and hyalinization were noticed in animals treated with base cream only (Figure 4d). Edema with inflammatory cells infiltration was detected in animals treated with creams containing 2.5% and 5% of JILE (Figure 4e,f), while animals treated with 10% JILE cream showed few inflammatory cells in subcutaneous tissue, and the skin layer remained intact, Figure 4g.

Figure 4.

Figure 4

Open in a new tab

Photomicrographs of subcutaneous and dermal tissues of treated rats. (a) healthy animals; (b) animals treated with carrageenan only; (c) 1% hydrocortisone cream; (d) base cream; (e) 2.5% JILE cream; (f) 5% JILE cream; (g) 10% JILE cream. Arrows refer to inflammatory cell infiltration.

2.4. UPLC-MS Analysis of Jatropha integerrima Extract

A total of 133 compounds were annotated in the extract representing different primary and secondary metabolites. Flavonoids and amino acids were eluted between 0–6 min, cyclic peptides were eluted from 9–11 min while diterpenoids, sterols, fatty acids, and fatty acid glycerides were eluted at the late part of the chromatographic run, Figure 5.

Figure 5.

Figure 5

Open in a new tab

Base peak chromatogram of the UPLC/MS analysis of J. integerrima leaves extract.

2.4.1. Phenolic Compounds

Analysis of the UPLC/MS chromatogram resulted in the identification of 19 flavonoids, 10 phenolic acid conjugates, 4 coumarins, and 1 lignan. Flavonoids occurred mainly as C-linked hexoses (11 flavonoids) which were readily identified by the neutral loss of 120 Da, Figure S1, as observed in peaks 10, 11, 13, 14, 19, 22, 24, 29, 30, 32 and 35 (Table 3, Figure 6). Most of the C-glycosides were derivatives of apigenin, including isoorientin (peak 11), vitexin (peak 13), and isovitexin (peak 14), which are reported here for the first time from J. integerrima. Vitexin (C-8 glycoside) was differentiated from its structural isomer isovitexin (C-6) by the intensity of the fragment ions at m/z 313 and 283, produced due to the cleavage of the C-attached sugar, Figure S2.

Table 3.

Annotated metabolites in leaves extract of Jatropha integerrima using UPLC/MS-Q-TOF analysis.

Peak No. tR (min) Experimental m/z [M + H]+ Molecular Formula Error (ppm) Fragments (m/z) Tentative Identification
Flavonoids
10 0.981 595.1656 C27H30O15 3.4 577, 433, 379, 367, 313, 283 Isovitexin-O-hexoside
11 2.68 449.1076 C21H20O11 2.3 431,383, 353, 339, 329, 299 Isoorientin
13 2.915 433.1116 C21H20O10 3.2 415, 379, 367, 337, 313, 283 Vitexin
14 3.13 433.1116 C21H20O10 3.2 415, 379, 337, 323, 313, 283 Isovitexin
16 3.4 449.1076 C21H20O11 2.9 431, 395, 287 Kaempferol O hexoside
19 3.67 560.1788 C27H29NO12 4.5 445, 427,409, 325, 295 Methylisovitexin proline
20 3.912 595.1672 C27H30O15 2.2 287, 271 Kaempferol O-rutinoside
22 4.05 771.2151 C37H38O18 2.6 675, 651,433,415, 313, 283, 177 Vitexin ferulate-O-hexoside
24 4.123 771.2111 C37H38O18 −2.6 675, 651,433,415, 313, 283, 177 Isovitexin ferulate hexoside
25 4.253 579.1708 C27H30O14 −0.4 433,417,399,351,321 297, 271 Apigenin O-rhamnoside-O-hexoside
26 4.396 433.1155 C21H20O11 4.6 271 Apigenin-O-hexoside
27 4.44 579.1717 C27H30O14 −1.5 271.0597 Apigenin-O-rutinoside
29 5.213 553.1329 C28H24O12 −1 433, 415,397,337,313, 295, 283, Vitexin p hydroxy benzoate
30 5.253 877.2175 C30H40O20 1.2 859, 757, 739, 455, 379, 325 Jatrophenol I/II/III
32 5.942 877.219 C30H40O20 0.5 859, 445, 427, 409,379,349,325 Jatrophenol I/II/III
33 6.06 639.1772 C32H30O14 2.1 415, 271,207 Apigenin sinapoyl hexose
34 6.13 609.159576 C31H28O13 2.4 489, 433, 397, 313, 283, 177 Apigenin ferulate-C-hexoside
35 6.215 736.2208 C33H36NO15 3.8 621,585,427,391,325, 295,177 Methylisovitexin proline ferulate ester
58 11.1 225.091 C15H12O2 0.0 197, 165, 105 Flavanone
Phenolic Acid Conjugates
21 3.98 417.1347 C18H24O11 −4.4 237,109 Cinnamic glycerol hexoside
23 4.06 503.1766 C22H30O13 1.4 485, 467, 383 Methyl-O-feruloylquinate diacetate
52 9.9 261.1852 C17H24O2 1.1 243, 201, 147, 119 Octyl cinnamic acid
56 10.57 221.1537 C14H20O2 5.0 203, 161, 151, 133, 123, 105 4-Heptylbenzoic acid
74 13 291.1958 C18H26O3 1.1 193, 123 Octyl-4-methoxycinnamate
76 13.1 235.17 C15H22O2 3.2 179,123,57 Octyl benzoate
106 19.5 401.3422 C27H44O2 2.0 191, 177, 137 Eicosenoyl benzoate
118 21.4 391.2837 C24H38O4 1.2 167,149 Tetradecyl ferulate
128 22.17 419.3153 C26H42O4 0.7 275, 293, 275,177, 127 Hexadecyl ferulate
129 23.4 463.3793 C29H50O4 2.4 445, 417, 177,139 Nonadecyl ferulate
Coumarins
12 2.9 193.0492 C10H18O4 137, 77,53 Scopoletin
15 3.31 223.0595 C11H10O5 2.7 149, 207, 121 Fraxidin
28 5.081 501.159 C22H28O13 2.5 339, 321, 177, 209 Methylhydroxycoumarin dihexoside
42 9.2 223.0738 C15H10O2 5.7 177, 149, 121 4-Phenyl coumarin
Nitrogenous Compounds
1 0.465 266.1604 C11H23NO6 2.2 248, 230, 116,104, 87 Choline hexoside
4 0.515 104.106585 C5H13NO 0.9 56.04, 58.06, 59.07, 60.07, 71 Choline
5 0.515 116.070497 C5H9NO2 0.9 70 L-Proline
6 0.541 144.100864 C7H13NO2 0 58, 84 Stachydrine
7 0.6 138.0549 C7H7NO2 0.4 136, 94,92,79,66 Amino benzoic acid
8 0.65 213.1241 C10H16N2O3 2.3 195, 177,135,121 Prolylproline
9 0.975 146.060114 C9H7NO 1.0 51, 65, 77, 91, 117, 118, 128 Indole carboxyaldehyde
73 12.96 270.3153 C18H39N 0.8 158 Octadecylamine
Cyclic Peptides
43 9.51 722.4826 C36H63N7O8 1.3 623, 510, 379, 280, 183 Cyclo (Val-leu-Leu-Val-Ser-Leu-Pro)
45 9.59 809.5482 C40H72N8O9 −1.8 722, 623, 605, 510, 280, 211 Cyclo (ABA-Val-leu-Leu-Val-Ser-Leu-Val)
46 9.6 767.5383 C38H70N8O8 −1.5 722, 704, 623, 510, 379 Cyclo (MeLys-leu-Leu-Val-Ser-Leu-Val)
47 9.7 652.4030 C31H53N7O8 0.24 634,521, 381, 268, 181 Integerrimacyclopeptide B
49 9.84 782.4596 C39H59N9O8 4.8 669, 651, 355, 284 Cyclogossine A
53 10.05 781.4595 C40H60N8O8 1.5 763, 668, 650, 555, 468 Integrimide A
54 10.53 767.5031 C37H66N8O9 0.7 749, 654, 636, 523, 394 Integerrimacyclopeptide A
55 10.55 668.430 C32H57N7O8 −3.2 650, 555, 537, 424,367,284,171 Cyclo (Leu-Leu-Gly-Thr-Leu-Ala-Val)
Diterpenes
31 5.814 317.2112 C20H28O3 0.6 299, 271, 231, 175, 173 Cleistanthol/ Jatrointelone C
37 6.88 291.1951 C18H26O3 1.3 255, 167 Triihydroxy-13- methylpodocarpane-triene
41 9.11 317.2110 C20H28O3 −0.06 299, 271,231,175 Jatrointelone C/ Cleistanthol
51 9.9 275.2008 C18H26O2 0.88 257,239, 173,159,119 Dihydroxy-13- methylpodocarpane-triene
59 11.36 301.21539 C20H28O2 2.7 283 239 227 218 185 Spruceanol
61 11.95 275.2016 C18H26O2 3.8 257, 173, 131, 91 Dihydroxy methylpodocarpane-8,10,13-triene isomer
63 11.98 315.1936 C20H26O3 5.9 231, 199, 133,123,81 Multifidone
67 12.4 411.2355 C22H34O7 5.4 351, 333, 369 Excolabdone C/ Isoforskolin
68 12.6 289.179 C18H24O3 −2.8 221, 205 Methyl podocarpate
70 12.7 671.3041 C36H46O12 −3.1 621, 593, 331 Premyrsinol propanoate-benzoate-triacetate
90 15.8 321.2428 C20H32O3 1.2 275, 257 Jatrodagricaine A
94 17.57 609.2703 C34H40O10 0.5 591, 531, 515, 273, 123 Diterpene benzoate triacetate
96 18 415.2391 C25H34O5 1.8 369, 313, 295 Deoxyingenol angelate
101 18.18 651.2815 C36H42O11 1.5 633, 601, 573, 483, 283 Diterpene benzoate tetracetate
103 18.65 593.2741 C34H40O9 −0.7 547, 533, 461, 447 Diterpene benzoate triacetate
104 18.85 575.3942 C34H54O7 0.1 309, 177 Phorbol-12-Myristate
110 20.15 695.307 C38H46O12 1.1 649, 563, 517 Diterpene benzoate pentacetate
112 20.37 653.2981 C36H44O11 2.4 609, 575,565, 549,503, 521 Euphorbiaproliferin F or isomer
113 20.4 637.3002 C36H44O10 −1.6 619, 587, 559 Peditithin H or isomer
114 20.52 637.3018 C36H44O10 0.8 619, 587,559, 473 Peditithin H or isomer
117 21.1 621.3045 C36H44O9 −1.8 561, 533,461,433, 193 Diterpene benzoate triacetate
119 21.46 431.2432 C25H34O6 0.9 231,165 Ingenol mebutate
123 21.9 665.3349 C38H48O10 4.3 619, 587, 559 Diterpene dibenzoate diacetate
126 22.03 681.3265 C38H48O11 −0.6 635, 593, 549, 503 Diterpene dibenzoate diacetate
Sesquiterpenoids
57 10.9 219.1751 C15H22O 3.0 203 Unidentified sesquiterpenoid
60 11.6 253.179 C15H24O3 3.2 197, 179, 141, 151 Ilicic Acid
75 13.06 235.1700 C15H22O2 3.2 179, 123,57 4-Patchoulen-15-oic acid
122 21.65 235.1697 C15H22O2 1.9 179, 81 Oxo-hydroxyguai-diene
Triterpenoids
107 20.03 441.3736 C30H48O2 2 423 287 235 189 149 Oxoamyrin
116 20.9 439.3573 C30H46O2 0.6 301, 233, 173, 149, 121 Dioxo-olean-12-ene
Fatty Acids and Their Conjugates
38 7.46 293.2125 C18H28O3 4.7 275, 257, 213, 195, 155 Oxo-phytodienoic acid
44 9.53 767.5324 C43H74O11 2.6 623, 511 GlcADG (34:3)
62 11.95 293.2113 C18H28O3 0.6 275, 257, 147, 133 Oxo-phytodienoic acid
64 12.26 319.2256 C20H30O3 −5.3 301 Oxo-eicosatetraenoic acid
65 12.4 313.2362 C18H32O4 3.6 295,277,151,95,81 Hydroperoxy-octadecadienoic acid
66 12.4 295.2278 C18H30O3 3.5 277,179,149,151, 137, 119 Oxo-octadecadienoic acid
69 12.63 277.2166 C18H28O2 1.4 259, 135,149, 121, 107 Octadecatetraenoic acid
71 12.85 295.2276 C18H30O3 2.8 277, 259, 231, 165 Hydroxy-Octadecatrienoic
72 12.86 351.2539 C21H34O4 2.9 277, 259, 179, 149,133 MG 18:4
77 13.48 520.3395 C26H50NO7P −0.9 502,184,104 LPC 18:2
78 13.5 295.2278 C18H30O3 6.2 277,179,149,151, 137,119 Hydroxy linoleinc acid
79 13.53 279.232 C18H30O2 0.5 149, 95, 81 Linolenic acid
80 13.7 465.2623 C22H41O8P 1.22 447,311,237, 155 PA: (10:1/ 9:0)
81 13.76 313.2734 C19H36O3 1.0 295, 277, 165, 123, 95 Oxononadecanoic acid
82 13.8 331.2899 C19H38O4 1.9 313, 257, 239, 123 2-Monopalmitin MG 16:0
83 13.94 295.2278 C18H30O3 3.5 277,179,149,151, 137, 119 Hydroxy-octadecatrienoic acid
84 14.08 467.2784 C22H44O8 P 2.17 393,313,239,155 PA (10:0/ 9:0)
85 14.1 295.2265 C18H30O3 0.9 277, 179, 151 Hydroxylinolenic acid
86 14.18 496.3403 C24H50NO7P −0.34 478,184,125, 104, 86 LPC 16:0
87 14.3 522.3580 C26H52NO7P 3.89 504,184,150, 104 LPC 18:1
88 15.3 291.1945 C18H26O3 3.3 273 249 203 147 Oxo-octadecatetraenoic acid
89 15.37 723.5084 C41H70O10 5.2 177, 133,89 MGDG 16:2, 16:2
91 16.095 524.3709 C26H54NO7P −1.36 506,184,104 LPC 18:0
92 16.19 305.2483 C20H32O2 2.6 259, 149, 135 Arachidonic acid
93 17.1 307.2631 C20H34O2 0.4 329, 307 Eicosatrienoic acid
95 17.64 323.2590 C20H34O3 2.0 305, 277, 179,151 Hydroxylinoleinic acic ethyl ester
97 18.06 331.2846 C19H38O4 0.9 313, 257, 239 1-Monopalmitin MG 16:0
98 18.07 699.5008 C39H70O10 4.6 625, 607, 429 MGDG 16:2, 14:0
99 18.07 353.2665 C21H36O4 4.0 2-Monolinolenin MG 18:3
100 18.08 745.483 C43H68O10 −5.5 699, 625, 415, 295 MGDG 16:3, 18:4
102 18.24 782.5670 C44H80NO8P −3.8 765,307 Phosphatidylcholine (18:2/18:2)
108 20.1 359.3145 C21H42O4 3.0 341, 285, 267, 123 Monosteirin
109 20.13 755.5713 C43H78O10 3.9 681,663,443,323 MGDG 18:2/16:0
111 20.15 381.2996 C23H40O4 0.9 none MG 20:3
115 20.89 549.4527 C34H60O5 2.5 531, 513, 287, 189, 121 DG 14:1/17:2
121 21.6 313.2723 C19H36O3 4.5 295, 277, 149, 133 Ricinoleate methyl esters
125 22 613.4828 C39H64O5 0.2 595, 335, 261 Dilinolenin DG 18:3/18:3
132 25.1 591.4920 C37H66O5 −6.3 573, 335,313,261 DG 18:3/16:0
Phytosterols
105 19.36 445.3630 C29H48O3 −4.6 427, 341, 185 Oxo-hydroxy sitosterol
120 21.55 413.3792 C29H48O 2.07 395, 159 Stigmasterol
124 21.9 429.3723 C29H48O2 0.9 411 Stigmast-4-en-6beta-ol-3-one
127 22.15 461.3616 C29H48O4 2.0 443, 401, 383, 187 Trihydroxystigmastan-6-one ene
130 23.5 415.3964.8 C29H50O 4.8 397, 341 Sitosterol
131 23.7 429.3729 C29H48O2 0.2 219, 205, 165 Stigmastane 3,6 dione
Jasmonates
36 6.263 265.1433 C15H20O4 0.5 247, 219,207,205,167,99 191 Abscisic acid
39 7.55 181.122163 C11H16O2 9.4 163,135, 121, 107, 99, 93 Jasmorolone
40 8.6 255.1498 C13H20O3 5.7 195, 179, 143,137 Methyljasmonate
Miscellaneous Compounds
2 0.47 365.1069 C14H20O11 2.6 203, 185 Ethyl aconitate hexoside
3 0.48 527.1584 C20H30O16 4.8 365, 347, 203, 185 Ethyl aconitate dihexoside
17 3.56 197.1168 C11H16O3 −2.1 179,161,135, 107 Loliolide/Epiloliolide
18 3.63 197.1170 C11H16O3 −1.2 179, 161, 133, 105, 91 Loliolide/Epiloliolide
48 9.8 409.166 C24H24O6 3.5 289, 121, 119 Benzyl shikonin
50 9.88 387.1793 C22H26O6 −2.3 267, 147, 121, 105 Eudesmin/epieudesmin
133 25.45 417.3652 C28H48O2 0.3 191, 151 Tocopherol
Open in a new tab

DG: diglyceride; LPC: lysophosphatidylcholine; MG: monoglyceride; MGDG: monoglyceridedi galactoside; PA: phosphatidic acid.

Figure 6.

Figure 6

Open in a new tab

Structures of selected compounds annotated in J. integerrima extract including flavonoids, peptides, and diterpenoids.

Two C-glycosides dimers were observed at 5.25 and 5.94 min (peaks of 30 and 32, respectively) with [M + H]+ at m/z 877.218 for C30H41O20 and were assigned to the isomeric jatrophenols I/II/III previously isolated from J. multifida [20]; they were also detected in two other Jatropha species [21]. These are dimers of isovitexin connected by a methylene bridge [22], Figure S3. Fragmentation of these dimers resulted in loss of isovitexin monomer (−432 Da) and appearance of methylisovitexin fragment ion at m/z = 445, Table 3, Figure S3. Two other peaks (peaks 19 and 35) produced the same fragment ion (m/z = 445) with [M+H]+ observed at m/z 560.1788 (for C27H30NO12) and 736.2208 (for C33H37NO15), respectively. Both peaks showed loss of proline amino acid as indicated by the neutral loss of 115 Da for C5H9NO2, Figure S4 and S5 and produced methylisovitexin fragment ions at m/z = 445 and 427. Therefore, peak 19 and 35 were annotated as methylisovitexin proline and methylisovitexin proline ferulate. To the best of our knowledge, this is the first report of isovitexin proline derivatives.

Meanwhile, flavonoids O-glycosides were characterized by the neutral loss of 162 Da for hexoses (peaks 10, 16, 22, 26), Figure S6, and 146 for rhamnosyl residue (peak 25) [23], Figure S7, Table 3.

Phenolic acids in J. integerrima extract were detected only as conjugated molecules substituted with medium or long aliphatic chains, as seen in peaks 52, 56, 74, 76,106, 118, 128, and 129. Among the annotated phenolic acid esters, only tetradecyl ferulate (peak 118) was previously reported in the genus and was isolated from both J. curcas [24] and J. multifida [25].

2.4.2. Nitrogenous Compounds

Eight simple nitrogenous compounds were annotated in J. integerrima extract, including choline and its glycoside (peaks 4 and 1, respectively). Other simple nitrogenous compounds included proline (peak 5) and its betaine derivative stachydrine (peak 6) in addition to proylproline (peak 8).

Apart from the simple nitrogenous compounds, 8 cyclic peptides (hepta-and octa-peptides) were observed between retention time of 9.5–10.5 min. Five cyclic peptides were previously isolated from the latex of J. integerrima [12,26,27] including integerrimide A (peak 53, [M + H]+ at m/z 781.4595 calculated for C40H61N8O8) [12], integrimmacyclopeptide A (peak 54, [M + H]+ at m/z 767.5031 calculated for C37H67N8O9), and integrrimacyclopeptide B (peak 47, [M + H]+ at m/z 652.4030 calculated for C31H54N7O8). Additionally, four cyclic peptides, which were not previously reported, were annotated in peaks 43, 45, 46, and 55, Figure 6. The amino acid sequence of these peptides was tentatively determined based on the high-resolution mass of their fragment ions Table S1, Figures S8–S11. These new cyclic peptides consisted mainly of hydrophobic residues including leucine or isoleucine (neutral loss of 113 Da, corresponding to C6H11NO) and valine (neutral loss of −99 Da corresponding to C5H9NO), Table S1, Figure 6.

2.4.3. Terpenoids

The most abundant group of secondary metabolites detected in J. integerrima leaves was that of terpenoids including sesquiterpenes (4 metabolites), diterpenes (24 metabolites) and two triterpenoids. To date, only free diterpenoids or their monoacetyl derivatives were reported in J. integerrima [14,15,28]. In this study, free diterpenoids were eluted first at retention time 5–11 min and were of cleistanthane, lathyrane, and podocarpane scaffold containing two or three oxygen atoms (peaks 31, 37, 41, 51, 59, 61, 63, and 68, Table 3, Figure 6, Figures S12–S14).

Meanwhile, diterpenoids esters were eluted at retention time 12–22 min and were mostly esters of jatrophane, phorbol, and ingenol. Acetate esters were predominant and were readily identified by the neutral loss of acetic acid (−60 Da) as seen in peaks 67, 70, 94, 112, 113, 114, and 117, while the presence of angelate ester (peak 96) was inferred from the neutral loss of 102 Da. Additionally esterification with benzoic acid was observed in late eluting peaks as indicated by the increase in double bond equivalent (14–16). These were observed in peaks 103 (C34H40O9), 110 (C38H46O12), 113,114 (C36H44O10), 117 (C36H44O9), 123 (C38H48O10), and 126 (C38H48O11) which showed multiple loss of acetate (−60 Da) and fragment ion at m/z 123 for benzoic acid, Figures S15 and S16. This substitution pattern of acetate and benzoate esters of a highly oxygenated skeleton has never reported before in J. integerrima. However, among Euphorbiaceae plants, molecules with highly oxygenated jatrophane, esterified with benzoic and acetic acid, were isolated from Pedilanthus tithymaloides and are designated as peditithin [29], and from Euphobia sanctae-catharinae are designated as euphosantiananes, [30,31]. Due to lack of extensive fragmentation of these high molecular weight esters, the exact carbon skeleton of these diterpenes could not be identified.

Among sesquiterpenes annotated in this study, an oxo-hydroxyguai-diene derivative was annotated (C15H22O2, peak 122), which was previously isolated from J. integerrima [11]. Two triterpenoids were annotated, namely, oxoamyrin and dioxo-olean-12-ene.

2.4.4. Fatty Acids and Their Conjugates

Fatty acids were detected as free fatty acid, fatty acid glycerides, phospholipids, and glycolipids, which together accounted for 38 metabolites. Unsaturated fatty acids C-18 were most abundant including oxo-phytodienoic (C18H28O3), linolenic (C18H30O2), hydroxylinoleinic (C18H30O3), oxo-octadecadienoic (C18H30O3) and ricinoleic acids. Several fatty acids derivatives were annotated in the extract including monoglyceride (MG), diglycerides (DG), monogalactosyl diglycerides (MGDG), phosphatidic acid esters (PA), and lysophasphatidyl choline (LPC).

Monoglycerides showed two consecutive loss of water (−18 Da), in addition to loss of −92 Da corresponding to loss of glycerol moiety (peaks 82, 108, and 111, Figure S17). Meanwhile, phosphatidic acid esters displayed a characteristic loss of 154 Da and appearance of a fragment ion at 155 amu corresponding to phosphopropionic acid (C3H7O5P) as seen in peaks 80 and 84, Table 3, Figure S18. Annotated phosphatidic acid esters were diglyceride with medium chain length (C-9 and C-10) and were observed in peaks 80 and 84. Fatty acid esters containing choline showed characteristic choline fragment at m/z 104.106 as in peaks 86, 87, and 91, Figure S19. Additionally, monogalactosyl diglycerides MGDG were identified in peaks 89, 98, 100, and 109, mainly as monoglycerides of C-16 or C-18 fatty acids.

2.4.5. Phytosterols and Other Compounds

Six phytosterols were annotated in the UPLC/MS chromatogram of J. integerrima including β-sitosterol, stigmasterol, stigmastane 3,6 dione and stigmast-4-en-6beta-ol-3-one, which all were previously reported in the genus Jatropha and the latter was isolated from J. integerrima. [11]. Three jasmonates (peaks 36, 39, and 40), two terpene lactones (peaks 17, 18), and tocopherol (peak 133) were also among annotated compounds.

2.5. Quantitative Determination of Secondary Metabolites

To gain possible insights into the relative abundance of secondary metabolites in J. integerrima extract, spectrophotometric methods were used to estimate the abundance of certain classes of secondary metabolites. Leaves’ extract of J. integerrima showed low abundance of phenolic compounds and flavonoids at 70.4 ± 0.4 mg GAE and 10.7 ± 0.1 mg QE per gram of extract, respectively. Meanwhile, results from vanillin/sulfuric assay indicated a high terpenoidal content of 149.7 mg UAE per gram of the extract.

3. Discussion

Leaves of Jatropha integerrima were used in South-East Asia (particularly in India and Bangladesh) for treatment of some inflammatory conditions such as arthritis and eczema. Other Jatropha species have well documented anti-inflammatory activity as proven by folk use, in vitro and in vivo assays [4,32,33]. Our investigation showed that Jatropha integerrima leaves extract (JILE) possess an anti-inflammatory effect when used in rat paw edema model. Both oral administration and topical application of the extract were able to reduce signs of inflammation (edema volume) and levels of inflammatory mediators (NO, TNF-α, PKC, and PGE2). Inflammation induced by carrageenan increased paw edema thickness and was associated with elevated levels of NO, TNF-α, PKC, and PGE2 after 4 h, as previously shown in other studies [34]. The involvement of NO and PGs in the modulation of inflammation is well established [35]. Lipid peroxidation initiated by the product of the reaction of NO with superoxide (peroxynitrite) liberates arachidonic acid from the cell membrane activating PGE2, which is one of the strongest inflammatory mediators [36]. Moreover, TNF-α induces NO synthesis by activating inducible nitric oxide synthase iNOS and augments the responses of neutrophils to inflammatory stimuli [37,38]. Activation of PKC mediates the activation of NF-κB, and secretion of TNF-α, IL-6, and IL-10 through TLR2/1 [39]; this may explain the elevation of PKC that provoked the increase in TNF-α serum level in our work.

Treatment with JILE decreased levels of these inflammatory mediators in a dose dependent manner and restored their basal levels at higher treatment dose of 400 mg/kg (per oral route) and using 10% strength cream (after topical application). Additionally, normal tissue structure was observed in animals receiving JILE treatment especially with topical application of 5% or 10% cream or using an oral dose of 400 mg/kg confirming the ability of JILE extract to inhibit inflammatory response.

The metabolomics profile of J. integerrima identified many compounds with known anti-inflammatory activity. For example, 19 flavonoidal compounds were detected in the extract which were mainly apigenin derivatives. Apigenin and its C-glycosides (vitexin and isovitexin) are known anti-inflammatory compounds that protect cells against oxidative stress and inflammation [40,41,42]. The major flavonodial compound in the extract (vitexin) was shown to reduce the levels of inflammatory cytokines such as IL4, IL5, and IL13 by 64%, 95%, and 65% in an induced asthma model at concentration of 1 mg/kg [43].

In addition to flavonoids, coumarins such as scopoletin and fraxidin have anti-inflammatory action mediated by their antioxidant potential [44,45,46]. Scopoletin can reduce inflammation and level of PGE2 in LPS stimulated cell lines [47].

Finally, nonpolar compounds such as triterpenes, sterols, and diterpenes are usually main contributors to anti-inflammatory activity of plant extracts. As reported previously, the nonpolar n-hexane fraction of Jatropha curcas extract had a better anti-inflammatory activity when tested in vitro compared to the polar fraction [33]. Additionally, J.integerrima extract was enriched with oxo and hydroxyl fatty acids (13 compounds, Table 3), which received attention recently due to their potential as anti-inflammatory agents and their indigenous role in regulating body inflammatory response [48].

4. Conclusions

These results suggest that the ethanol extract of the leaves of Jatropha integerrima possess a significant anti-inflammatory effect, both through oral administration and topical application. This effect can be attributed to its high content of flavonoids, terpenoids, and oxygenated fatty acids, which are represented in the metabolomics profile of the extract by 65 compounds. Our findings encourage further investigation of the rich metabolome of J. integerrima to identify novel anti-inflammatory compounds.

5. Material and Methods

5.1. Plant Material

Fresh leaves of Jatropha integerrima Jacq. were collected from plants cultivated at the Medicinal, Aromatic and Poisonous Plants Experimental Station of the Faculty of Pharmacy, Cairo University (Giza, Egypt). Plant identity was confirmed by Therese Labib, consultant of plant taxonomy at the Ministry of Agriculture and Orman Botanical Garden (Giza, Egypt). Vouchered herbarium specimen (code numbers 582018III) was deposited at the Pharmacognosy Department, Faculty of Pharmacy, Cairo University.

5.2. Preparation of Plant Extract

Fresh leaves were air dried in shade and reduced to powder. The powdered leaves (1 kg) were extracted with absolute ethanol by cold maceration till exhaustion (4 × 5 L). The solvent was then removed by vacuum distillation at a temperature not exceeding 40 °C, and the dried ethanol extract was kept in an air-tight container at 4 °C till use.

5.3. Determination of Total Phenolic Content

Total phenolic content of J. integerrima leaves extract was carried out using the Folin–Ciocalteu method following the optimized assay procedures described by Blainski, Lopes, and de Mello [49]. The total phenolic content was expressed as mg gallic acid equivalent (GAE)/g of extract using a standard calibration curve of gallic acid (20–200 μg/mL).

5.4. Determination of Flavonoid Content

Total flavonoid content was determined by measuring the yellow color developed upon reacting flavonoids with AlCl3 reagent according to optimized assay conditions described by Silva et al. [50]. The total flavonoid content was expressed in mg quercetin equivalent (QE)/g of extract based on pre-established calibration curve of quercetin (0.1–0.7 mg/mL).

5.5. Determination of Steroidal/Terpenoidal Content

Spectrophotometric estimation of total steroidal and/or terpenoid content was carried out based on the chromogenic reaction produced upon treatment of the extract with vanillin/ sulfuric acid reagent according to the protocol developed by V. Le et al. [51]. The color developed was measured at λ = 544 nm, and total steroid and/or terpenoid content was expressed as ursolic acid equivalent (UAE mg/g of extract) as deduced from a pre-established calibration curve using standard ursolic acid (20–160 μg/mL).

5.6. Ultra-Performance Liquid Chromatography Analysis

Liquid chromatography instrument (Sciex, TripleTOF 5600+, Framingham, MA, USA) was used for chromatographic separation. A reversed phase C18 analytical column (Waters, Xbridge C18, 2.1 × 50 mm, 3.5 µm particle size) was used at 40 °C. Leaves extract (50 mg) was dissolved in 1 mL of water: methanol: acetonitrile (50:25:25) and centrifuged for 5 min at 10,000 rpm followed by filtration through a membrane disc filter. Twenty microliters were diluted to 1 mL and 10 µL of this solution was injected into the system. Gradient elution was carried out at a flow rate of 0.3 mL/min using eluent A (0.1% formic acid in deionized water) and eluent B (100% acetonitrile). Elution was performed according to the following gradient: 10% B, 0–1 min; 10%–90% B, 1–25 min; 90%–10% B, 25–28 min.

5.7. High Resolution Quadrpole-Time of Flight Mass Analysis

UPLC system was coupled to electrospray ion source with quaderpole-time of flight mass analyzer (ESI-QTOF, Framingham, MA, USA). MS analysis was performed in positive ion mode; cone voltage, 30 eV; capillary voltage, 3 kV; desolvation temperature, 450 °C; cone gas flow, 50 L/h and desolvation gas flow, 900 L/h. Time of flight mass scan (TOF-MS, Framingham, MA, USA) was controlled using Analyst TF 1.7.1 and was recorded over m/z range 50–1000. TOF MS/MS scan was done in information dependent acquisition over the same mass range. UPLC-MS/MS data were processed with PeakView 2.2 (Framingham, MA, USA) for data extraction.

5.8. Anti-Inflammatory Assay

5.8.1. Animals

Adult male Wister albino rats (7–8 weeks old, weighing 130–180 g) were housed in standard cages (10 rats/cage) under pathogen-free conditions and maintained at controlled room temperature (21–24 °C) with a 40–60% relative humidity and under normal dark-light cycles. All animals had free access to rat chew diet and water ad libitum. All procedures were approved by the Animal Care Committee of the National Research Centre.

5.8.2. Acute Toxicity Study

Rats were divided into two groups of 12 rats each (6 males and 6 females). The extract of J. integerrima was suspended in distilled water and given orally to rats of the first group in a single dose of 5 g/kg. The control group received the same volumes of distilled water. The percentage mortality for the extract was recorded for 24 h. Animals were observed for 14 days, for any changes in skin, fur, respiratory, circulatory, central nervous system, somatomotor activity, and behavior pattern. Particular observation for tremors, convulsions, salivation, diarrhea, lethargy, sleep, and coma were also recorded.

5.8.3. Carrageenan Induced Paw Edema

Anti-inflammatory activity was evaluated using carrageenan induced paw edema. Paw swelling was elicited by subplantar injection of 100 μL of 1% sterile lambda carrageenan suspension in saline into the right hind paw [35]. Contralateral paw received an equal volume of saline solution. The edema component of inflammation was quantified by measuring hind footpad immediately before carrageenan injection and 1–4 h after carrageenan injection with a micrometer caliber [52]. Edema was expressed as a percentage of change from control (predrug) values. Rats, to be injected with carrageenan, were divided into nine groups each of 10 animals. Group 1 (control group): where rats received oral saline (0.2 mL/rat); group 2: rats were given indomethacin (25 mg/kg); groups 3 and 4: rats received the extract of J. integerrima (200 mg/kg and 400 mg/kg), respectively. Indomethacin and the extracts were given orally 60 min before the injection of the carrageenan suspension.

5.8.4. Skin Irritation Test

Twelve rats were divided into two groups (six rats each), namely, control and test groups. Hairs of rat hind paw were shaved, and rats of different groups were kept in separate cages for seven days. An amount (0.3 g) of 10% cream was placed on the shaved skin (4 cm2) for rats of the test group while the other group received only base cream. The area was covered with a cotton bandage and any sensitivities were assessed and graded.

5.8.5. Topical Anti-Inflammatory Activity

The base cream was prepared according to recipe by Franyoto et al.( 2018) [53] containing stearic acid (142 g), glycerine (100 g), sodium tetraborate (2.5 g), triethanolamine (10 g), methyl paraben (0.1 g) and 750 mL of distilled water. The base cream was then mixed with the ethanol extract of the leaves of Jatropha integerrima at three different concentrations (2.5%, 5%, and 10%) [53].

Before edema induction as described in Section 5.8.3, rats were divided into six groups each of 10 rats. Group 1 was left untreated, while animals in group 2 were given a single topical dose (0.3 g) of market product of hydrocortisone (1%). Group 3 rats received a single topical dose (0.3 g) of base cream, while animals in groups 4, 5, and 6 received 0.3 g of the cream extract of J. integerrima at concentrations of 2.5%, 5%, and 10%, respectively. An amount of 0.3 g of the tested cream was used 30 min before injection of the carrageenan suspension, and it was gently rubbed 50 times with the index finger. A separate group of healthy animals were kept as a control group. Edema was expressed as a percentage change from control (predrug) values [54].

5.8.6. Blood Samples and Biochemical Analysis

Four hours after carrageenan injection and immediately after measuring edema volume, animals were anesthetized with urethane (1.5 g/kg; i.p.) and blood samples were taken from the abdominal aorta and used for determination of PGE2 using Abnova ELISA Kit, TNF-α using Cusabio ELISA Kit, and PKC by enzyme linked immunoassay (ELISA) technique using standard kits (Glory Science Co., Ltd, Louisiana, LA, USA).

5.8.7. Histological Examination

Paws were fixed in 10% formalin solution and dehydrated in ascending grades of alcohol and embedded in paraffin. Sections at four-micron thickness were taken and stained with hematoxylin and eosin (H&E).

5.9. Statistical Analysis

All the values are presented as mean ± standard error of the means (SE). Comparisons between different groups were carried out using one-way analysis of variance (ANOVA), followed by Tukey’s HSD test for multiple comparisons. Graph pad Prism software, version 5 (GraphPad Software Inc., San Diego, CA, USA), was used to carry out statistical tests. The difference was considered significant when p < 0.05.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/plants11020218/s1, Figure S1: MS/MS spectrum of peak 29: Vitexin-p-hydroxybenzoate; Figure S2: Fragmentation pattern highlighting different fragmentation of the two structural isomer vitexin and isovitaxin based on the intensity of 313 and 283 fragment ions; Figure S3: MS/MS spectrum of peaks 30 and 32: Jatrophenol I/II/III; Figure S4: MS/MS spectrum of peak 35: Proline methylisovitexin; Figure S5: MS/MS spectrum of peak 35: Methylisovitexin proline ferulate; Figure S6: MS/MS spectrum of peak 26: Apigenin-O-hexoside; Figure S7: MS/MS spectrum of peak 25: Apigenin-O-hexoside-O-rhamnoside; Figure S8: MS/MS spectrum of peak 43: A cycloheptapeptide; Figure S9: MS/MS spectrum of peak 45: A cyclooctapeptide; Figure S10: MS/MS spectrum of peak 46: A cycloheptapeptide; Figure S11: MS/MS spectrum of peak 46: A cycloheptapeptide; Figure S12: MS/MS spectrum of peak 59: Spruceanol; Figure S13: MS/MS spectrum of peak 61; Figure S14: MS/MS for peak 67: Isoforskolin; Figure S15: MS/MS for peak 114: Premyrsinol/peditithin derivatives; Figure S16: MS/MS of peak 125: Premyrsinol/peditithin derivative; Figure S17: MS/MS of peak 82: Monopalmitin; Figure S18: MS/MS of peak 84: Phosphatidic acid (10:0/9:0); Figure S19: MS/MS of peak 86: Lysophosphatidylcholine (16:0/0:0); Table S1: Analysis of high resolution MS/MS Q-TOF fragments for newly identified cyclic peptides.

Click here for additional data file. (1.2MB, zip)

Author Contributions

Conceptualization: S.M.E.-Z. and A.M.S.; methodology, A.H.E.; software, E.A.M.; validation, A.A.A.S. and A.H.E.; formal analysis, A.H.E. and E.A.M.; investigation, A.H.E., E.A.M. and A.A.A.S.; resources, S.M.E.-Z. and A.M.S.; data curation, E.A.M.; writing—original draft preparation, E.A.M. and A.A.A.S.; writing—review & editing, A.H.E. and S.M.E.-Z.; supervision, A.M.S. and S.M.E.-Z. All authors have read and agreed to the published version of the manuscript.

Data Availability Statement

All data related to this article are presented in this manuscript or available as supplementary material.

Conflicts of Interest

The authors declare no conflict of interest.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Cavalcante N.B., Diego da Conceição Santos A., Guedes da Silva Almeida J.R. The genus Jatropha (Euphorbiaceae): A review on secondary chemical metabolites and biological aspects. Chem. Biol. Interact. 2020;318:108976. doi: 10.1016/j.cbi.2020.108976. [DOI] [PubMed] [Google Scholar]
  • 2.Srinivasan N., Palanisamy K., Mulpuri S. Jatropha: Phytochemistry, Pharmacology, and Toxicology. In: Mulpuri S., Carels N., Bahadur B., editors. Jatropha, Challenges for a New Energy Crop. Springer; Singapore: 2019. pp. 415–435. [Google Scholar]
  • 3.Sabandar C.W., Ahmat N., Jaafar F.M., Sahidin I. Medicinal property, phytochemistry and pharmacology of several Jatropha species (Euphorbiaceae): A review. Phytochemistry. 2013;85:7–29. doi: 10.1016/j.phytochem.2012.10.009. [DOI] [PubMed] [Google Scholar]
  • 4.Salim M.N., Masyitha D., Harris A., Balqis U., Iskandar C.D., Hambal M. Darmawi Anti-inflammatory activity of Jatropha curcas Linn. latex in cream formulation on CD68 expression in mice skin wound. Vet. World. 2018;11:99–103. doi: 10.14202/vetworld.2018.99-103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Abdulkarim B., Al-Maqtari T., Al-Doaiss A.A., Dhabali A.A.H. Antioxidant, antimicrobial and wound healing potential of Jatropha variegata -An interesting plant endemic to Yemen. Pakistan J. Biol. Sci. 2020;23:1581–1590. doi: 10.3923/pjbs.2020.1581.1590. [DOI] [PubMed] [Google Scholar]
  • 6.Hernandez-Hernandez A.B., Alarcon-Aguilar F.J., Garcia-Lorenzana M., Rodriguez-Monroy M.A., Canales-Martinez M.M. Jatropha neopauciflora Pax latex exhibits wound-healing effect in normal and diabetic mice. J. Evid.-Based Integr. Med. 2021;26:2515690X2098676. doi: 10.1177/2515690X20986762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Verardo G., Baldini M., Ferfuia C., Gorassini A. Rapid and selective screening for toxic phorbol esters in Jatropha curcas seed oil using high-performance liquid chromatography-electrospray ionization-tandem mass spectrometry. J. Chromatogr. A. 2019;1597:63–75. doi: 10.1016/j.chroma.2019.03.015. [DOI] [PubMed] [Google Scholar]
  • 8.Roach J.S., Devappa R.K., Makkar H.P.S., Becker K. Isolation, stability and bioactivity of Jatropha curcas phorbol esters. Fitoterapia. 2012;83:586–592. doi: 10.1016/j.fitote.2012.01.001. [DOI] [PubMed] [Google Scholar]
  • 9.Akhter A., Rahman M.S., Ahsan M. Preliminary antimicrobial and cytotoxic activities of n-hexane extract of Jatropha pandurifolia. Lat. Am. J. Pharm. 2008;27:918–921. [Google Scholar]
  • 10.Wagh V.V., Jain A.K. Ethnopharmacological survey of plants used by the Bhil and Bhilala ethnic community in dermatological disorders in Western Madhya Pradesh, India. J. Herb. Med. 2020;19:100234. doi: 10.1016/j.hermed.2018.09.005. [DOI] [Google Scholar]
  • 11.Sutthivaiyakit S., Mongkolvisut W., Prabpai S., Kongsaeree P. Diterpenes, sesquiterpenes, and a sesquiterpene−coumarin conjugate from Jatropha integerrima. J. Nat. Prod. 2009;72:2024–2027. doi: 10.1021/np900342b. [DOI] [PubMed] [Google Scholar]
  • 12.Mongkolvisut W., Sutthivaiyakit S., Leutbecher H., Mika S., Klaiber I., Möller W., Rösner H., Beifuss U., Conrad J. Integerrimides A and B, cyclic heptapeptides from the latex of Jatropha integerrima. J. Nat. Prod. 2006;69:1435–1441. doi: 10.1021/np0602012. [DOI] [PubMed] [Google Scholar]
  • 13.Zhu J.-Y., Cheng B., Zheng Y.-J., Dong Z., Lin S.-L., Tang G.-H., Gu Q., Yin S. Enantiomeric neolignans and sesquineolignans from Jatropha integerrima and their absolute configurations. RSC Adv. 2015;5:12202–12208. doi: 10.1039/C4RA15966G. [DOI] [Google Scholar]
  • 14.Zhang D.-B., Wang Z., Liang Y.-N., Yu J.-G., Zhang Z., Liu S.-J., Zhang Z., Song Z.-X., Tang Z.-S., Duan D.-Z. Jatrophainolides A–C, new cembrane-type diterpenoids with PTP1B inhibitory activity from the root bark of Jatropha integerrima. Phytochem. Lett. 2020;36:166–170. doi: 10.1016/j.phytol.2020.02.007. [DOI] [Google Scholar]
  • 15.Zhu J.-Y., Lou L.-L., Guo Y.-Q., Li W., Guo Y.-H., Bao J.-M., Tang G.-H., Bu X.-Z., Yin S. Natural thioredoxin reductase inhibitors from Jatropha integerrima. RSC Adv. 2015;5:47235–47243. doi: 10.1039/C5RA07274C. [DOI] [Google Scholar]
  • 16.Mohammed A.E., Al-Keridis L.A., Rahman I., Alotaibi M.O., Suliman R.S., Alrajhi A.M., Elobeid M.M., Alothman M.R., Alhomaidi E.A., Korany S.M. Silver Nanoparticles Formation by Jatropha integerrima and LC/MS-QTOF-Based Metabolite Profiling. Nanomaterials. 2021;11:2400. doi: 10.3390/nano11092400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Eshilokun A.O., Kasali A.A., Ogunwande I.A., Walker T.M., Setzer W.N. Chemical composition and antimicrobial studies of the essential oils of Jatropha integerrima Jacq (leaf and seeds) Nat. Prod. Commun. 2007;2:853–855. doi: 10.1177/1934578X0700200813. [DOI] [Google Scholar]
  • 18.Xu D.-P., Zhou Y., Zheng J., Li S., Li A.-N., Li H.-B. Optimization of ultrasound-assisted extraction of natural antioxidants from the flower of Jatropha integerrima by response surface methodology. Molecules. 2016;21:18. doi: 10.3390/molecules21010018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Cong H.H., Khaziakhmetova V.N., Zigashina L.E. Rat paw oedema modeling and NSAIDs: Timing of effects. Int. J. Risk Saf. Med. 2015;27:S76–S77. doi: 10.3233/JRS-150697. [DOI] [PubMed] [Google Scholar]
  • 20.Marzouk M.S., Moharram F.A., Haggag E.G., El-Batran S.M., Mahmoud I.I., Ibrahim R.R. Novel biflavone diglycosides and biological activity of Jatropha multifida leaves. Chem. Nat. Compd. 2012;48:765–770. doi: 10.1007/s10600-012-0377-z. [DOI] [Google Scholar]
  • 21.Zengin G., Mahomoodally M.F., Sinan K.I., Ak G., Etienne O.K., Sharmeen J.B., Brunetti L., Leone S., Di Simone S.C., Recinella L., et al. Chemical composition and biological properties of two Jatropha species: Different parts and different extraction methods. Antioxidants. 2021;10:792. doi: 10.3390/antiox10050792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Moharram F., Marzouk M., Haggag E., El-Batran S., Ibrahim R. Biological examination and novel biflavone di-C-glycosides from Jatropha multifida L. leaves. Planta Med. 2007;73:P048. doi: 10.1055/s-2007-986830. [DOI] [Google Scholar]
  • 23.Mekky R.H., Thabet M.M., Rodríguez-Pérez C., Elnaggar D.M.Y., Mahrous E.A., Segura-Carretero A., Abdel-Sattar E. Comparative metabolite profiling and antioxidant potentials of seeds and sprouts of three Egyptian cultivars of Vicia faba L. Food Res. Int. 2020;136:109537. doi: 10.1016/j.foodres.2020.109537. [DOI] [PubMed] [Google Scholar]
  • 24.Ravindranath N., Ravinder Reddy M., Ramesh C., Ramu R., Prabhakar A., Jagadeesh B., Das B. New lathyrane and podocarpane diterpenoids from Jatropha curcas. Chem. Pharm. Bull. 2004;52:608–611. doi: 10.1248/cpb.52.608. [DOI] [PubMed] [Google Scholar]
  • 25.Das B., Ravikanth B., Laxminarayana K., Ramarao B., Raju T.V. New Macrocyclic diterpenoids from Jatropha multifida. Chem. Pharm. Bull. 2009;57:318–320. doi: 10.1248/cpb.57.318. [DOI] [PubMed] [Google Scholar]
  • 26.Welé A., Baraguèye C., Ndiaye W., Fall D., Ndoye I., Diop Y., Dubosq L., Bodo B. [Cytotoxic activity of two cyclic peptides from the latex of Jatropha integerrima Euphorbiaceae] Dakar Med. 2007;52:209–215. [PubMed] [Google Scholar]
  • 27.Idrissa N., Adama D., Mamadou B., Rokhaya S., Yoro T., Alassane W., Djibril F. Novel cytotoxic cycloheptapeptide from the Latex of Jatropha integerrima. J. Chem. Pharm. Res. 2016;8:135–139. [Google Scholar]
  • 28.Sutthivaiyakit S., Mongkolvisut W., Ponsitipiboon P., Prabpai S., Kongsaeree P., Ruchirawat S., Mahidol C. A novel 8,9-seco-rhamnofolane and a new rhamnofolane endoperoxide from Jatropha integerrima roots. Tetrahedron Lett. 2003;44:3637–3640. doi: 10.1016/S0040-4039(03)00704-4. [DOI] [Google Scholar]
  • 29.Zhu J., Wang R., Lou L., Li W., Tang G., Bu X., Yin S. Jatrophane diterpenoids as modulators of P-glycoprotein-dependent multidrug resistance (MDR): Advances of structure-activity relationships and discovery of promising MDR reversal agents. J. Med. Chem. 2016;59:6353–6369. doi: 10.1021/acs.jmedchem.6b00605. [DOI] [PubMed] [Google Scholar]
  • 30.Hegazy M.-E., Hamed A., Ibrahim M., Talat Z., Reda E., Abdel-Azim N., Hammouda F., Nakamura S., Matsuda H., Haggag E., et al. Euphosantianane A–D: Antiproliferative premyrsinane diterpenoids from the endemic Egyptian plant Euphorbia sanctae-catharinae. Molecules. 2018;23:2221. doi: 10.3390/molecules23092221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Elshamy A.I., Mohamed T.A., Al-Rowaily S.L., Abd-ElGawad A.M., Dar B.A., Shahat A.A., Hegazy M.-E.F. Euphosantianane E–G: Three new premyrsinane type diterpenoids from Euphorbia sanctae-catharinae with Contribution to chemotaxonomy. Molecules. 2019;24:2412. doi: 10.3390/molecules24132412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Mujumdar A., Misar A. Anti-inflammatory activity of Jatropha curcas roots in mice and rats. J. Ethnopharmacol. 2004;90:11–15. doi: 10.1016/j.jep.2003.09.019. [DOI] [PubMed] [Google Scholar]
  • 33.Othman A.R., Abdullah N., Ahmad S., Ismail I.S., Zakaria M.P. Elucidation of in-vitro anti-inflammatory bioactive compounds isolated from Jatropha curcas L. plant root. BMC Complement. Altern. Med. 2015;15:11. doi: 10.1186/s12906-015-0528-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Abd El-Alim S.H., Kassem A.A., Basha M., Salama A. Comparative study of liposomes, ethosomes and transfersomes as carriers for enhancing the transdermal delivery of diflunisal: In vitro and in vivo evaluation. Int. J. Pharm. 2019;563:293–303. doi: 10.1016/j.ijpharm.2019.04.001. [DOI] [PubMed] [Google Scholar]
  • 35.Salvemini D., Wang Z.-Q., Bourdon D.M., Stern M.K., Currie M.G., Manning P.T. Evidence of peroxynitrite involvement in the carrageenan-induced rat paw edema. Eur. J. Pharmacol. 1996;303:217–220. doi: 10.1016/0014-2999(96)00140-9. [DOI] [PubMed] [Google Scholar]
  • 36.Mariotto S., Suzuki Y., Persichini T., Colasanti M., Suzuki H., Cantoni O. Cross-talk between NO and arachidonic acid in inflammation. Curr. Med. Chem. 2007;14:1940–1944. doi: 10.2174/092986707781368531. [DOI] [PubMed] [Google Scholar]
  • 37.Salim T., Sershen C.L., May E.E. Investigating the role of TNF-α and IFN-γ activation on the dynamics of iNOS gene expression in LPS stimulated macrophages. PLoS ONE. 2016;11:e0153289. doi: 10.1371/journal.pone.0153289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Saini R., Singh S. Inducible nitric oxide synthase: An asset to neutrophils. J. Leukoc. Biol. 2019;105:49–61. doi: 10.1002/JLB.4RU0418-161R. [DOI] [PubMed] [Google Scholar]
  • 39.Loegering D.J., Lennartz M.R. Protein kinase C and toll-like receptor signaling. Enzyme Res. 2011;2011:1–7. doi: 10.4061/2011/537821. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.He M., Min J.-W., Kong W.-L., He X.-H., Li J.-X., Peng B.-W. A review on the pharmacological effects of vitexin and isovitexin. Fitoterapia. 2016;115:74–85. doi: 10.1016/j.fitote.2016.09.011. [DOI] [PubMed] [Google Scholar]
  • 41.Peng Y., Gan R., Li H., Yang M., McClements D.J., Gao R., Sun Q. Absorption, metabolism, and bioactivity of vitexin: Recent advances in understanding the efficacy of an important nutraceutical. Crit. Rev. Food Sci. Nutr. 2021;61:1049–1064. doi: 10.1080/10408398.2020.1753165. [DOI] [PubMed] [Google Scholar]
  • 42.Ginwala R., Bhavsar R., Chigbu D.I., Jain P., Khan Z.K. Potential role of flavonoids in treating chronic inflammatory diseases with a special focus on the anti-inflammatory activity of apigenin. Antioxidants. 2019;8:35. doi: 10.3390/antiox8020035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Venturini C.L., Macho A., Arunachalam K., de Almeida D.A.T., Rosa S.I.G., Pavan E., Balogun S.O., Damazo A.S., de Oliviera Martins D.T. Vitexin inhibits inflammation in murine ovalbumin-induced allergic asthma. Biomed. Pharmacother. 2018;97:143–151. doi: 10.1016/j.biopha.2017.10.073. [DOI] [PubMed] [Google Scholar]
  • 44.Whang W.K., Park H.S., Ham I., Oh M., Namkoong H., Kim H.K., Hwang D.W., Hur S.Y., Kim T.E., Park Y.G., et al. Natural compounds, fraxin and chemicals structurally related to fraxin protect cells from oxidative stress. Exp. Mol. Med. 2005;37:436–446. doi: 10.1038/emm.2005.54. [DOI] [PubMed] [Google Scholar]
  • 45.Jamuna S., Karthika K., Paulsamy S., Thenmozhi K., Kathiravan S., Venkatesh R. Confertin and scopoletin from leaf and root extracts of Hypochaeris radicata have anti-inflammatory and antioxidant activities. Ind. Crops Prod. 2015;70:221–230. doi: 10.1016/j.indcrop.2015.03.039. [DOI] [Google Scholar]
  • 46.Ding Z., Dai Y., Hao H., Pan R., Yao X., Wang Z. Anti-Inflammatory effects of scopoletin and underlying mechanisms. Pharm. Biol. 2008;46:854–860. doi: 10.1080/13880200802367155. [DOI] [Google Scholar]
  • 47.Kim H.-J., Jang S.I., Kim Y.-J., Chung H.-T., Yun Y.-G., Kang T.-H., Jeong O.-S., Kim Y.-C. Scopoletin suppresses pro-inflammatory cytokines and PGE2 from LPS-stimulated cell line, RAW 264.7 cells. Fitoterapia. 2004;75:261–266. doi: 10.1016/j.fitote.2003.12.021. [DOI] [PubMed] [Google Scholar]
  • 48.Kolar M.J., Konduri S., Chang T., Wang H., McNerlin C., Ohlsson L., Härröd M., Siegel D., Saghatelian A. Linoleic acid esters of hydroxy linoleic acids are anti-inflammatory lipids found in plants and mammals. J. Biol. Chem. 2019;294:10698–10707. doi: 10.1074/jbc.RA118.006956. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Blainski A., Lopes G., de Mello J. Application and analysis of the Folin Ciocalteu Method for the determination of the total phenolic content from Limonium brasiliense L. Molecules. 2013;18:6852–6865. doi: 10.3390/molecules18066852. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Silva Mathias M., Rodrigues de Oliveira R. Differentiation of the phenolic chemical profiles of Cecropia pachystachya and Cecropia hololeuca. Phytochem. Anal. 2019;30:73–82. doi: 10.1002/pca.2791. [DOI] [PubMed] [Google Scholar]
  • 51.Le A.V., Parks E.S., Nguyen M.H., Roach P.D. Improving the vanillin-sulphuric acid method for quantifying total saponins. Technologies. 2018;6:84. doi: 10.3390/technologies6030084. [DOI] [Google Scholar]
  • 52.Salama A., Kotb R., Shaker R. Effect of treatment durability and coloration of coated cotton fabrics on antibacterial, UV-blocking, healing and anti-inflammatory properties. J. Chem. Pharm. Res. 2015;7:181–193. [Google Scholar]
  • 53.Franyoto Y.D., Kusmita L., Mutmainah, Angrena R.D. Total flavonoid content and formulation antioxidant cream stem of Jatropha multifida L. J. Phys. Conf. Ser. 2018;1025:012130. doi: 10.1088/1742-6596/1025/1/012130. [DOI] [Google Scholar]
  • 54.Pashmforosh M., Rajabi Vardanjani H., Rajabi Vardanjani H., Pashmforosh M., Khodayar M.J. Topical anti-inflammatory and analgesic activities of Citrullus colocynthis extract cream in rats. Medicina (B. Aires) 2018;54:51. doi: 10.3390/medicina54040051. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (1.2MB, zip)

Data Availability Statement

All data related to this article are presented in this manuscript or available as supplementary material.

Articles from Plants are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES